AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL635, an investigational antibody antagonist targeting neurokinin 3 receptor (NK3R) that is being developed for the non-hormonal treatment of moderate-to-severe vasomotor symptoms (VMS), commonly known as hot flashes, associated with menopause.
'Vasomotor symptoms of menopause affect millions of women, with significant impacts on their well-being, and their personal and professional lives,' said Natalya Nazarenko, MD, Executive Medical Director at AbCellera. 'We are excited to advance ABCL635 into a Phase 1 trial and explore it as a potential non-hormonal, long-acting treatment option to address these highly disruptive symptoms.'
The Phase 1 study is anticipated to begin in Q3 of 2025 and will evaluate ABCL635's safety, pharmacokinetics, and pharmacodynamics in healthy participants and postmenopausal women with moderate-to-severe VMS.
About ABCL635
ABCL635 is a potential first-in-class antibody medicine for the non-hormonal treatment of moderate-to-severe vasomotor symptoms (VMS), commonly known as hot flashes, associated with menopause. ABCL635 specifically targets NK3R, a clinically validated G-coupled protein receptor (GPCR) expressed on kisspetin, neurokinin, and dynorphin (KNDy) neurons in the infundibular nucleus of the hypothalamus. ABCL635 is the first program from AbCellera's GPCR and ion channel platform to advance into the pipeline. A Phase 1 clinical trial is anticipated to begin in Q3 of 2025.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera's platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
AbCellera Forward-Looking Statements
This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management's current beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize, and achieve market acceptance of our current and planned products and services, our research and development efforts, and other matters regarding our business strategies, use of capital, results of operations and financial position, and plans and objectives for future operations.
In some cases, you can identify forward-looking statements by the words 'may,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'intend,' 'plan,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'continue,' 'ongoing' or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors are described under 'Risk Factors,' 'Management's Discussion and Analysis of Financial Condition and Results of Operations,' and elsewhere in the documents we file with the Securities and Exchange Commission from time to time. We caution you that forward-looking statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent our views as of the date hereof. We undertake no obligation to update any forward-looking statements for any reason, except as required by law.
1 Lé AM, Torres T. Pharmaceutics. 2022 Dec 8;14(12):2753.
2 Guttman-Yassky E, et al. 2024 Sep 18;191(4):488-496.
3 Weidinger S, et al. J Allergy Clin Immunol. 2024 Nov 8:S0091-6749(24)01175-8.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners' Spring 2025 Spotlight Series
Click here to register Discussion will focus on company's May 2025 meeting with the FDA to review the statistically significant responder analysis results for the subgroup of breast cancer patients in company's recently conducted Phase 3 OnTarget trial The currently estimated US metastatic breast cancer population potentially qualifies as an orphan population, in alignment with company's core focus on orphan diseases Company plans to promptly pursue authorization to initiate expanded access program for patients with breast cancer who may not be eligible for a potential pivotal treatment trial with crofelemer in patients with metastatic breast cancer SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / June 9, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today issued a reminder that Lisa Conte, the company's founder, president and CEO, will participate in a virtual fireside chat at 9:00 AM Eastern tomorrow, Tuesday, June 10, 2025, as part of Lytham Partners' spring 2025 Spotlight Series. Participation Instructions for Jaguar Health's Virtual Fireside Chat During Lytham Partners Spring 2025 Spotlight Series When: Tuesday, June 10, 2025 from 9:00 - 10:00 AM Eastern Where: Online (Click Here). The fireside chat will also be available for replay following the event. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that Jaguar management will participate in a virtual fireside chat June 10, 2025 as part of Lytham Partners' spring 2025 Spotlight Series, Jaguar's expectation that the currently estimated US metastatic breast cancer population may qualify as an orphan population, and Jaguar's expectation that it will promptly pursue authorization to initiate an expanded access program for patients with breast cancer who may not be eligible for a potential pivotal treatment trial with crofelemer in patients with metastatic breast cancer patients. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Source: Jaguar Health, Inc. Contact: hello@ Jaguar-JAGX SOURCE: Jaguar Health, Inc.
Yahoo
an hour ago
- Yahoo
Nicholas Academic Centers Celebrates Class of 2025 With Stories of Grit, Growth, and Giving Back
SANTA ANA, Calif., June 09, 2025--(BUSINESS WIRE)--One of the four featured Nicholas Academic Centers (NAC) scholars was not expected to survive childbirth. "Before I opened my eyes to this world, I shared my first eight months of life alongside cancer," stated Tanesha Bravo. Injecting her grandmother with insulin, caring for her mother's medical issues, losing her best friend to leukemia, and surviving her own surgeries to remove a hemangioma fueled Bravo's goal of becoming a surgical oncologist. This fall, she heads to Chapman University on a full scholarship as a biochemistry and molecular biology major. Her path has been shaped by the fragility and power of life, inspired by her mother's unwavering strength as she battled illness while working long hours to support her children. An immigrant at age 12, Bravo helped her mom deliver groceries and food while maintaining top grades. The NAC, which provides highly qualified staff, academic assistance and tutoring, social services, cultural enrichment programs, college access and support services, and need-based scholarship opportunities for students, became her second home, providing the guidance and resources she needed to turn a once-distant dream into reality. "I was given a second chance at life," Bravo said. "I couldn't have achieved everything without the NAC, and now I want to be that support for others." On June 6, 2025, Broadcom cofounder Dr. Henry T. Nicholas III hosted the NAC, elected officials, and community members at the 17th annual NAC graduation ceremony to honor the Class of 2025, 198 graduates who collectively earned 1,736 college acceptances, as they advance to prestigious colleges. NAC Alumni Santa Ana Unified School District (SAUSD) Board Clerk Valerie Magdaleno (Class of 2016) and law student Lisbeth Rosales (Class of 2018) gave encouraging words to the NAC Class of 2025 and the community at the graduation ceremony. The NAC is generously funded by the Henry T. Nicholas III Education Foundation and was founded by Dr. Nicholas and Retired Superior Court Judge Jack Mandel in 2007. Dr. Nicholas has donated $57.7 million to support the three NAC locations in downtown Santa Ana, Valley High School, and Century High School. "Seventeen years later, we are a community that has changed for the better, with more and more students not just getting their bachelor's degrees, but also going on to get their master's, and some even their PhD," said Rodolfo Duarte, Executive Director of the NAC and a fellow NAC alumnus, who jokes about having spent half of his life at the NAC. During long nights studying at the NAC which served as her anchor, Stephania Salvador, the daughter of Mexican immigrants, her father a restaurant server, her mother a catering worker, often thought about her parents' sacrifices, including her father leaving college to provide for the family. A natural leader, Salvador served as senior class president. She also founded a volunteer club and used a $5,000 grant to run a sports camp for special needs children. She is University of Pennsylvania bound on a full scholarship to become a real estate lawyer. "I want to help solve the housing crisis, especially for low-income communities like mine," she explained. Salvador hopes to support her parents and uplift her community through her legal career. Adrian Ramirez discovered early on that reading and analyzing history helped him make sense of the present and imagine a better future. He started at the NAC with a goal to simply get into any college to honor his Mexican-born parents' sacrifices and wishes; NAC expanded his horizon to Harvard University on a full scholarship, where he will major in government, with plans to become an attorney. Ramirez served as president of the National Honor Society, led book drives for local libraries, and promoted civic engagement through Santa Ana Youth Votes. He also spread joy through Origami for Good, creating origami art to donate to children at hospitals, the elderly, and soldiers. Ramirez thanks Dr. Nicholas for "creating a program that showed me that I'm capable of doing so much more than I can even imagine." UC Berkeley-bound Bryan Figueroa dreams of returning to Santa Ana to help his community the way "Dr. Nick has," who "believed in the NAC scholars when they didn't always believe in themselves." The son of a carpenter and a house cleaner, one of Figueroa's first memories was being pushed in a stroller by his mother and collecting cans and bottles to make a few extra dollars. Fueled by these moments, he made a quiet promise to carry their dreams forward. In a full-circle moment, he joined his high school's recycling club. Figueroa has also mentored younger generations through Big Brothers Big Sisters and volunteered for other nonprofits. He plans to major in mathematics to build a career that can support both his family and the community. "The NAC flipped a switch that college was possible," he reflected. "I realized this wasn't just about me. It was about honoring my family's sacrifices." NAC Class of 2025 Highlights: 100% high school graduation (national average of 87%) 100% enrolled directly into college 88% enrolled directly into four-year institutions 96% first-generation college students 95% Latino students NAC Alumni Highlights: A total of 2,498 NAC graduates have earned over $154.2 million in scholarships and grants 95% Latino, 3% Asian American, 2% Other 96% are first-generation college students 75% have enrolled directly into four-year institutions 93% who enrolled in four-year universities have graduated or currently remain enrolled (national average retention rate of 78%) 55% who attended four-year universities graduated in four years (California average of 50%; national Latino average of 32%) 86% who attended four-year universities graduated in six years (national average of 64%; national Latino average of 54%) 13% who completed a bachelor's degree also completed/enrolled in a graduate degree program (national Latino average of 7%) 17th Annual NAC Booklet Press Packet View source version on Contacts MEDIA INQUIRIES: Susan Kang GroupSusan@ (714) 299-0322 Sign in to access your portfolio
Business Wire
an hour ago
- Business Wire
Nicholas Academic Centers Celebrates Class of 2025 With Stories of Grit, Growth, and Giving Back
SANTA ANA, Calif.--(BUSINESS WIRE)--One of the four featured Nicholas Academic Centers (NAC) scholars was not expected to survive childbirth. 'Before I opened my eyes to this world, I shared my first eight months of life alongside cancer,' stated Tanesha Bravo. Injecting her grandmother with insulin, caring for her mother's medical issues, losing her best friend to leukemia, and surviving her own surgeries to remove a hemangioma fueled Bravo's goal of becoming a surgical oncologist. This fall, she heads to Chapman University on a full scholarship as a biochemistry and molecular biology major. Her path has been shaped by the fragility and power of life, inspired by her mother's unwavering strength as she battled illness while working long hours to support her children. An immigrant at age 12, Bravo helped her mom deliver groceries and food while maintaining top grades. The NAC, which provides highly qualified staff, academic assistance and tutoring, social services, cultural enrichment programs, college access and support services, and need-based scholarship opportunities for students, became her second home, providing the guidance and resources she needed to turn a once-distant dream into reality. 'I was given a second chance at life,' Bravo said. 'I couldn't have achieved everything without the NAC, and now I want to be that support for others.' On June 6, 2025, Broadcom cofounder Dr. Henry T. Nicholas III hosted the NAC, elected officials, and community members at the 17 th annual NAC graduation ceremony to honor the Class of 2025, 198 graduates who collectively earned 1,736 college acceptances, as they advance to prestigious colleges. NAC Alumni Santa Ana Unified School District (SAUSD) Board Clerk Valerie Magdaleno (Class of 2016) and law student Lisbeth Rosales (Class of 2018) gave encouraging words to the NAC Class of 2025 and the community at the graduation ceremony. The NAC is generously funded by the Henry T. Nicholas III Education Foundation and was founded by Dr. Nicholas and Retired Superior Court Judge Jack Mandel in 2007. Dr. Nicholas has donated $57.7 million to support the three NAC locations in downtown Santa Ana, Valley High School, and Century High School. 'Seventeen years later, we are a community that has changed for the better, with more and more students not just getting their bachelor's degrees, but also going on to get their master's, and some even their PhD,' said Rodolfo Duarte, Executive Director of the NAC and a fellow NAC alumnus, who jokes about having spent half of his life at the NAC. During long nights studying at the NAC which served as her anchor, Stephania Salvador, the daughter of Mexican immigrants, her father a restaurant server, her mother a catering worker, often thought about her parents' sacrifices, including her father leaving college to provide for the family. A natural leader, Salvador served as senior class president. She also founded a volunteer club and used a $5,000 grant to run a sports camp for special needs children. She is University of Pennsylvania bound on a full scholarship to become a real estate lawyer. 'I want to help solve the housing crisis, especially for low-income communities like mine,' she explained. Salvador hopes to support her parents and uplift her community through her legal career. Adrian Ramirez discovered early on that reading and analyzing history helped him make sense of the present and imagine a better future. He started at the NAC with a goal to simply get into any college to honor his Mexican-born parents' sacrifices and wishes; NAC expanded his horizon to Harvard University on a full scholarship, where he will major in government, with plans to become an attorney. Ramirez served as president of the National Honor Society, led book drives for local libraries, and promoted civic engagement through Santa Ana Youth Votes. He also spread joy through Origami for Good, creating origami art to donate to children at hospitals, the elderly, and soldiers. Ramirez thanks Dr. Nicholas for 'creating a program that showed me that I'm capable of doing so much more than I can even imagine.' UC Berkeley-bound Bryan Figueroa dreams of returning to Santa Ana to help his community the way 'Dr. Nick has,' who 'believed in the NAC scholars when they didn't always believe in themselves.' The son of a carpenter and a house cleaner, one of Figueroa's first memories was being pushed in a stroller by his mother and collecting cans and bottles to make a few extra dollars. Fueled by these moments, he made a quiet promise to carry their dreams forward. In a full-circle moment, he joined his high school's recycling club. Figueroa has also mentored younger generations through Big Brothers Big Sisters and volunteered for other nonprofits. He plans to major in mathematics to build a career that can support both his family and the community. 'The NAC flipped a switch that college was possible,' he reflected. 'I realized this wasn't just about me. It was about honoring my family's sacrifices.' NAC Class of 2025 Highlights: 100% high school graduation (national average of 87%) 100% enrolled directly into college 88% enrolled directly into four-year institutions 96% first-generation college students 95% Latino students NAC Alumni Highlights: 17th Annual NAC Booklet
